BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 26489686)

  • 1. A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients.
    Ligocki AJ; Rivas JR; Rounds WH; Guzman AA; Li M; Spadaro M; Lahey L; Chen D; Henson PM; Graves D; Greenberg BM; Frohman EM; Ward ES; Robinson W; Meinl E; White CL; Stowe AM; Monson NL
    ASN Neuro; 2015; 7(5):. PubMed ID: 26489686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients.
    Rivas JR; Ireland SJ; Chkheidze R; Rounds WH; Lim J; Johnson J; Ramirez DM; Ligocki AJ; Chen D; Guzman AA; Woodhall M; Wilson PC; Meffre E; White C; Greenberg BM; Waters P; Cowell LG; Stowe AM; Monson NL
    Acta Neuropathol; 2017 Jan; 133(1):43-60. PubMed ID: 27730299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach.
    Ota M; Sato N; Okamoto T; Noda T; Araki M; Yamamura T; Kunugi H
    Mult Scler Relat Disord; 2015 Nov; 4(6):515-20. PubMed ID: 26590657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant forms of myelin antigens expressed on Chinese hamster ovary (CHO) cells as a tool for identification of autoantibodies in serum of multiple sclerosis patients.
    Jaśkiewicz E; Michałowska-Wender G; Pyszczek A; Wender M
    Folia Neuropathol; 2010; 48(1):45-8. PubMed ID: 20383810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
    Lily O; Palace J; Vincent A
    Brain; 2004 Feb; 127(Pt 2):269-79. PubMed ID: 14662514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen microarrays identify CNS-produced autoantibodies in RRMS.
    Quintana FJ; Farez MF; Izquierdo G; Lucas M; Cohen IR; Weiner HL
    Neurology; 2012 Feb; 78(8):532-9. PubMed ID: 22262743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-GM1 antibodies are not associated with cerebral atrophy in patients with multiple sclerosis.
    Valentino P; Labate A; Nisticò R; Pirritano D; Cerasa A; Liguori M; Bastone L; Crescibene L; Quattrone A
    Mult Scler; 2009 Jan; 15(1):114-5. PubMed ID: 18845652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivity to AQP4 epitopes in relapsing-remitting multiple sclerosis.
    Alexopoulos H; Kampylafka EI; Chatzi I; Travasarou M; Karageorgiou KE; Dalakas MC; Tzioufas AG
    J Neuroimmunol; 2013 Jul; 260(1-2):117-20. PubMed ID: 23673145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of autoantibody profiles for cerebrospinal fluid biomarker discovery in patients with relapsing-remitting multiple sclerosis.
    Beyer NH; Lueking A; Kowald A; Frederiksen JL; Heegaard NH
    J Neuroimmunol; 2012 Jan; 242(1-2):26-32. PubMed ID: 22177943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
    Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
    Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of self-reactive IgG antibody repertoires in patients with relapsing-remitting multiple sclerosis.
    Lionel A; de Seze J; Didier L; Sandrine FN; Sylvain D; Patrick V; Lionel P
    Immunol Lett; 2005 Feb; 97(1):55-62. PubMed ID: 15626476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of antibody reactivity in paired cerebrospinal fluid and serum of a relapsing remitting multiple sclerosis patient.
    Govarts C; Somers K; Hupperts R; Stinissen P; Somers V
    Autoimmunity; 2009; 42(8):699-704. PubMed ID: 19835487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients.
    Cross AH; Stark JL; Lauber J; Ramsbottom MJ; Lyons JA
    J Neuroimmunol; 2006 Nov; 180(1-2):63-70. PubMed ID: 16904756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transglutaminase-6 is an autoantigen in progressive multiple sclerosis and is upregulated in reactive astrocytes.
    Cristofanilli M; Gratch D; Pagano B; McDermott K; Huang J; Jian J; Bates D; Sadiq SA
    Mult Scler; 2017 Nov; 23(13):1707-1715. PubMed ID: 28273770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis.
    Ahlbrecht J; Martino F; Pul R; Skripuletz T; Sühs KW; Schauerte C; Yildiz Ö; Trebst C; Tasto L; Thum S; Pfanne A; Roesler R; Lauda F; Hecker M; Zettl UK; Tumani H; Thum T; Stangel M
    Mult Scler; 2016 Aug; 22(9):1202-14. PubMed ID: 26493127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of antibodies in multiple sclerosis.
    Weber MS; Hemmer B; Cepok S
    Biochim Biophys Acta; 2011 Feb; 1812(2):239-45. PubMed ID: 20600871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis.
    Blauth K; Zhang X; Chopra M; Rogan S; Markovic-Plese S
    Clin Immunol; 2015 Apr; 157(2):121-32. PubMed ID: 25596452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells.
    Matarese G; Carrieri PB; La Cava A; Perna F; Sanna V; De Rosa V; Aufiero D; Fontana S; Zappacosta S
    Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5150-5. PubMed ID: 15788534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial antibody library from multiple sclerosis patients reveals antibodies that cross-react with myelin basic protein and EBV antigen.
    Gabibov AG; Belogurov AA; Lomakin YA; Zakharova MY; Avakyan ME; Dubrovskaya VV; Smirnov IV; Ivanov AS; Molnar AA; Gurtsevitch VE; Diduk SV; Smirnova KV; Avalle B; Sharanova SN; Tramontano A; Friboulet A; Boyko AN; Ponomarenko NA; Tikunova NV
    FASEB J; 2011 Dec; 25(12):4211-21. PubMed ID: 21859892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis.
    Elong Ngono A; Lepetit M; Reindl M; Garcia A; Guillot F; Genty A; Chesneau M; Salou M; Michel L; Lefrere F; Schanda K; Imbert-Marcille BM; Degauque N; Nicot A; Brouard S; Laplaud DA; Soulillou JP
    J Immunol Res; 2015; 2015():673503. PubMed ID: 26090495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.